Vascular Biogenics Ltd.

VBL Therapeutics, is a clinical stage biopharmaceutical company focused on discovery, development and commercialization of first-in-class treatments for cancer.

Suggest edits

Raised

$24.5M

Follow us

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Add info

Latest funding

$2,489,422

Grant - 2017

Israel Innovation Authority

$22,000,000

Secondary market - 2016

Team Size

10+

Employees

I work here

$2,489,422 Grant

Index

By TNW

Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

Overview

Funding 2

VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy Genetic Engineering & Biotechnology News - Biotec...